Filing Flows

Filing Flows › ICU Medical (ICUI) › Q1 2026

ICU Medical (ICUI) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 7, 2026

ICU Medical (ICUI) reported revenue of $530M for the first quarter 2026 (Q1 2026), -12% from a year earlier. Operating margin was 2.6%, net earnings $30.1M (5.7% of revenue).

Revenue$530M
Year over year-12%
Quarter over quarter—
Operating margin2.6%
Net earnings$30.1M

ICU Medical, Q1 2026: revenue $530M (-12% year over year), operating margin 2.6%, net earnings $30.1M, operating cash flow $38.9M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$530M—-12%
Operating profit$13.6M-1%+5%
Net earnings$30.1M——
Operating cash flow$38.9M—-24%
Free cash flow$27.6M—-25%

What changed

Revenue was $530.2M in Q1 2026, down 12% year over year. Infusion Consumables was the largest line at 52% of revenue. Vital Care lost $99.8M year over year (down 58%), 134% of the total change.

Gross margin was 38.9%, up 4.1 points from Q1 2025. Operating profit was $13.6M, a 2.6% margin (up 0.4 points year over year). Operating expenses fell 2% while revenue fell 12%. Net earnings were $30.1M.

Operating cash flow was $38.9M (down 24% year over year), 129% of net earnings. Non-cash charges added back $50.0M of depreciation and amortization and $14.0M of share-based compensation. Working capital and other items used $55.3M. After purchase of property, plant and equipment, net ($11.3M), free cash flow as the company reports it was $27.6M.

Questions

What was ICU Medical's revenue in the first quarter 2026?

ICU Medical (ICUI) reported revenue of $530M for the first quarter 2026 (Q1 2026), -12% from a year earlier.

Was ICU Medical profitable in the first quarter 2026?

Operating profit was $13.6M (2.6% of revenue) and net earnings $30.1M.

Open the interactive Sankey →

Source: ICU Medical 10-Q on SEC EDGAR.